The referenced study https://www.nature.com/articles/s41551-023-01086-2 https://www.nature.com/articles/s41551-023-01086-2 says "a mouse model" and "non-human p

The referenced study https://www.nature.com/articles/s41551-023-01086-2 https://www.nature.com/articles/s41551-023-01086-2 says "a mouse model" and "non-human primates": "We show that pGal–antigen therapy induces antigen-specific tolerance in a mouse model...as well as the suppression of antigen-specific responses to vaccination against a DNA-based simian immunodeficiency virus in non-human primates" The article also mentions that phase I trials have been carried out with humans: "initial phase I safety trials have already been carried out in people with celiac disease...and phase I safety trials are underway in multiple sclerosis"